Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. - Wikidata - awgldk - TriplyDB

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

http://www.wikidata.org/entity/Q43806478

about

Psychostimulants and cognition: a continuum of behavioral and cognitive activation Medical and genetic differences in the adverse impact of sleep loss on performance: ethical considerations for the medical profession Drug therapy for obstructive sleep apnoea in adults Drug therapy for obstructive sleep apnoea in adults Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life A Practical Approach to Excessive Daytime Sleepiness: A Focused Review New developments in the use of positive airway pressure for obstructive sleep apnea Approved and investigational uses of modafinil : an evidence-based review Association of sleep adequacy with more healthful food choices and positive workplace experiences among motor freight workers Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.Recognizing and managing obstructive sleep apnea in primary care.Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning.Sleep-disordered breathing, control of breathing, respiratory muscles, and pulmonary function testing in AJRCCM 2001.An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep.Should a pharmaceutical be approved for the broad indication of excessive sleepiness?Sleep x 9: an approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery Emerging drugs for narcolepsy.Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review.Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis Evaluation of the safety of modafinil for treatment of excessive sleepiness Management of cancer-related fatigue.Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag.Obstructive sleep apnea, hypertension, and wakefulness-promoting agents.Excessive daytime sleepiness in sleep apnea: it is not just apnea hypopnea index.Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.Obesity and obstructive sleep apnea-hypopnea syndrome.Obstructive sleep apnea - management update.The SomnuSeal Oral Mask Is Reasonably Tolerated by Otherwise CPAP Noncompliant Patients with OSA.Adjunctive use of modafinil in bipolar patients: just another stimulant or not?Pharmacotherapy of obstructive sleep apnea.Modafinil in the treatment of excessive sleepiness.Optimal treatment of obstructive sleep apnea and excessive sleepiness.Recognition and management of excessive sleepiness in the primary care setting.Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment Adult obstructive sleep apnoea.

P2860

Q22242285-00F74CBD-C438-46AC-A398-E2F6B5401C3B Q23923348-7397DCA0-11DD-4879-ACFC-768A43D21616 Q24202857-B65E2B7A-8FE4-484D-B802-24D92A7805E4 Q24246054-64516D96-5F62-4884-A1C8-19A1720CDF75 Q24654140-06EDB9F0-8E43-4C91-9015-F2801372609F Q24678942-93E95EFB-41E0-4B76-8949-9A96D0AAB38B Q26738489-0B8C48E2-E239-4722-8B07-67C5987DD31C Q26783732-5B7E47E9-9F89-4159-9DD7-8AF57206F2AB Q28291968-35B96007-C3BA-4F6A-A218-EA8A999C0D61 Q28391936-79218A8B-7378-4D92-802C-306E5DDDB69C Q28535752-536900BE-9AB0-4205-931E-DFA50AFB8D9A Q33155044-F27998B7-6103-4BB5-8ADD-34C1511DC026 Q33526244-00D8570D-2771-4B4A-9721-DF9B86510554 Q33908171-7E50C9F1-452E-4473-A7F9-1A4A2023F519 Q34550128-4FA7B1A1-CF17-4F0C-B633-5FCFA6EC7ADD Q34608494-61580692-A5DC-40C8-A8A4-3857008E9A1E Q34889485-F2E3B7C4-39AC-414E-B073-C552CABFB13C Q35043788-344BF2EE-BBFC-4270-BD6F-05C67F0E1563 Q35537752-E386D1FD-10B6-40BC-882C-39BB661626C0 Q35967388-A57A8DA8-2EB4-4C86-A9BD-1B815F768323 Q35995466-B7D06DB4-BAC5-4713-81AE-A6D089D3D4A1 Q36070925-CAD80221-B13B-4FFE-A3AD-4016734871AA Q36090687-8CD99E13-F592-40A3-95C8-A3E58F8EE6D3 Q36099680-E0E45BC6-2415-4352-9E02-D348F66E9842 Q36156911-61253643-40E6-4CFE-9CCA-54586EDD008F Q36373026-64635FC3-FC36-4341-973E-E2B31DCCD396 Q36779795-B8151D82-644C-4D9E-97EC-523DD64A3E19 Q36905151-19233740-B017-49EA-B4AA-8D2FC3F572CB Q36982720-C6EE008C-CA59-4B32-8011-4185D16F53A8 Q37027841-9B3A6AA1-8847-4104-8AC1-D319119C90B7 Q37118017-C44204F2-5AEE-4CC2-AE9F-40CB7D431BAE Q37165729-8B60F2C2-22D0-4142-BAE3-79B218FAC750 Q37280182-1E1A1130-E5E6-472E-871A-83F4F5E043A1 Q37316115-9FC16515-87D2-4380-90AE-F3540E0C21BA Q37362650-70A61B11-002A-4BAB-96F0-9B4F4D92B52E Q37385592-83A079B1-779B-4791-BBDA-1F757A7A4A69 Q37428910-3FF341C7-3382-45F4-9E39-3F1E6B26600E Q37429694-0FF5014F-D811-47B6-BBDC-0EF9F8B8A759 Q37474097-CF7FE863-FBD8-454E-AD03-16C7B41B5D7C Q37540226-A67DCA0E-5B94-4EC9-9047-F95071F4AE75

P2860

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

http://www.wikidata.org/entity/Q43806478

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@en

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@nl

type

label

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@en

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@nl

prefLabel

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@en

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@nl

P1433

Q43806478-0261CF1C-9B75-41F3-BA8C-C708553B2A95

P1476

Q43806478-4D0BF45A-4544-4E87-893F-2EA7E82660FB

P2093

Q43806478-69C64309-E038-41E1-ABD6-DA7159AA5AD6

Q43806478-6CC6D0C9-55BD-4C33-B392-8EE9990A3A96

Q43806478-816A1332-1D21-4ABE-84A6-9DF761973D99

Q43806478-DE492F9A-6339-47B7-81F0-775BFF84BAE2

P2860

Q43806478-017BF9C1-61F2-47D8-BBDF-8447269D395A

Q43806478-05A4BAE1-5390-4259-8947-E605A07CA6D2

Q43806478-064103B9-7A7F-4786-860F-A9770B3FAD54

Q43806478-07EB755D-42B8-4FCC-B72E-4FF84B320D6D

Q43806478-08598878-1A0B-442E-8CAF-3C0292DAD7CF

Q43806478-0D05232C-A90E-484C-852B-3844231BF960

Q43806478-1328365D-2ED3-4DC9-AF8A-7A8AE5299597

Q43806478-246B09BF-98A6-464A-B82A-AA4C75793233

Q43806478-25B2196E-2397-4D78-A677-BB1B81C31713

Q43806478-28E79995-E92B-4D3B-8E73-DD1E82CF90A0

P304

Q43806478-4AED6AAA-B05B-466F-A944-9D101BBC555B

P31

Q43806478-5F9AC07E-87F2-4CB8-B037-25EDED7FE551

P356

Q43806478-5B70D3F0-CED9-4770-8B1B-4C015E475922

P407

Q43806478-38AE8BDD-5411-4D74-B370-5B2889A73D4B

P433

Q43806478-2B7DD2F5-EE4C-4BC5-B01D-9FA35C240DAF

P478

Q43806478-71ADCCCD-DBC4-4E08-99AE-D409DDC81025

P577

Q43806478-89F2BE92-A0CC-4AF7-BFB9-D8DC5E9825C8

P5875

Q43806478-949D0867-B5EB-47B0-8181-B30DCECE1768

P698

Q43806478-31958862-A0F0-40E4-92F2-367799059052

P921

Q43806478-708F0466-3512-4482-9F22-E81D19F34185

P356

AJRCCM.164.9.2103032

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

@en

P2093

Black JE

http://www.w3.org/2001/XMLSchema#string

Matheson JK

http://www.w3.org/2001/XMLSchema#string

Pack AI

http://www.w3.org/2001/XMLSchema#string

Schwartz JR

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

A new method for measuring daytime sleepiness: the Epworth sleepiness scale

The occurrence of sleep-disordered breathing among middle-aged adults

Prospective study of the association between sleep-disordered breathing and hypertension

Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement.

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep.

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.

Cardiopulmonary consequences of obstructive sleep apnea.

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.

P304

1675-1681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.164.9.2103032

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11636764

http://www.w3.org/2001/XMLSchema#string

P698

11719309

http://www.w3.org/2001/XMLSchema#string

P921